News tagged with lymphoma
Jarid2 may break the Polycomb silence
Historically, fly and human Polycomb proteins were considered textbook exemplars of transcriptional repressors, or proteins that silence the process by which DNA gives rise to new proteins. Now, work by a ...
Apr 30, 2012 |
5 / 5 (1) |
0
|
Microbiologists identify two molecules that kill lymphoma cells in mice
Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.
Nov 06, 2011 |
5 / 5 (5) |
2
|
A better target for B-cell lymphomas: From a library of MAG antagonists to nanomolar CD22 ligands
Patients suffering from B-cell lymphomas can be treated with antibodies directed against the B-lymphocyte antigen CD20.
Oct 25, 2011 |
not rated yet |
0
|
Cancer-stricken British girl's 'Bucket List' is Internet hit
A cancer-stricken British teenage girl said Thursday she had been overwhelmed by messages of support from around the world after writing an online "Bucket List" of things she wanted to do before dying.
Jun 09, 2011 |
not rated yet |
0
Worm studies shed light on human cancers
(PhysOrg.com) -- Research in the worm is shedding light on a protein associated with a number of different human cancers, and may point to a highly targeted way to treat them.
Apr 21, 2011 |
not rated yet |
0
|
Pacific salmon may be dying from leukemia-type virus
In Canada's Fraser River, a mysterious illness has killed millions of Pacific salmon, and scientists have a new hypothesis about why: The wild salmon are suffering from viral infections similar to those linked to some forms ...
Apr 18, 2011 |
5 / 5 (3) |
3
AIDS associated with an increased risk of some stomach, esophageal cancers
Among people with AIDS, the risk of stomach and esophageal malignancies is higher than among the general population, according to study results presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
Apr 04, 2011 |
not rated yet |
0
Two proteins play key roles in Burkitt's lymphoma
Burkitt's lymphoma is one of the most aggressive tumors affecting humans. Multiple alterations in genes that regulate cell proliferation rate explain its aggressive behavior.
Mar 07, 2011 |
5 / 5 (1) |
0
Researchers predict age of T cells to improve cancer treatment
Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body's own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin's ...
Mar 02, 2011 |
not rated yet |
0
|
Radiation helps cure Hodgkin’s lymphoma, but future cancer risk a concern
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy ...
Feb 16, 2011 |
not rated yet |
0
Safety of biologic treatment for arthritis depends on the drug
Some biologic drugs may be safer than others according to a new systematic review by Cochrane researchers. Biologics are a broad class of drugs based on biological molecules. The drugs are used to reduce inflammation in diseases ...
Medicine & Health / Medications
Feb 16, 2011 |
5 / 5 (2) |
0
Computer-assisted diagnosis tools to aid pathologists
Researchers are leveraging Ohio Supercomputer Center resources to develop computer-assisted diagnosis tools that will provide pathologists grading Follicular Lymphoma samples with quicker, more consistently ...
Medicine & Health / Medical research
Jan 31, 2011 |
not rated yet |
0
Study reveals how fusion protein triggers cancer
What happens when two proteins join together? In this case, they become like a power couple, where the whole is greater than the sum of the parts.
Jan 27, 2011 |
4.3 / 5 (3) |
1
|
FDA sees possible cancer risk with breast implants
(AP) -- Federal health officials said Wednesday they are investigating a possible link between breast implants and a very rare form of cancer after reviewing a handful of cases reported over the last 13 years.
Jan 26, 2011 |
not rated yet |
1
Patent awarded for method to dampen immune response
National Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating antigen receptors on their surfaces. The method, discovered by John Cambier, PhD, Chairman of the Integrated Department ...
Medicine & Health / Medical research
Jan 18, 2011 |
not rated yet |
1
Lymphoma
Lymphoma is a type of cancer that originates in lymphocytes of the immune system. They often originate in lymph nodes, presenting as an enlargement of the node (a tumor). Lymphomas are closely related to lymphoid leukemias, which also originate in lymphocytes but typically involve only circulating blood and the bone marrow (where blood cells are generated in a process termed haematopoesis) and do not usually form static tumours. There are many types of lymphomas, and in turn, lymphomas are a part of the broad group of diseases called hematological neoplasms.
Thomas Hodgkin published in 1832 the first description of lymphoma, specifically of the form named after him, Hodgkin's lymphoma. Since then many other forms of lymphoma have been described, grouped under several proposed classifications. The 1982 Working formulation classification became very popular. It introduced the category non-Hodgkin lymphoma (NHL), itself divided into 16 different diseases. However, since these different lymphomas have little in common with each other, the NHL label is of limited usefulness for doctors or patients and is slowly being abandoned. The latest classification by the WHO (2001) lists 43 different forms of lymphoma divided in four broad groups.
Some forms of lymphoma are indolent (e.g. small lymphocytic lymphoma), compatible with a long life even without treatment, whereas other forms are aggressive (e.g. Burkitt's lymphoma), causing rapid deterioration and death. The prognosis therefore depends on the correct classification of the disease, established by a pathologist after examination of a biopsy.
Although older classifications referred to histiocytic lymphomas, these are recognized in newer classifications as of B, T or NK cell lineage. True histiocytic malignancies are rare and are classified as sarcomas.
For more information about Lymphoma, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.